Cardiovascular Disease Monitoring and Diagnostic Devices Market
Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis By Product (ECG Systems, Holter Monitors, Implantable Loop Recorders & Others) By End-User and By Region – Global Market Insights 2022 to 2027
Analysis of Cardiovascular Disease Monitoring and Diagnostic Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Cardiovascular Disease Monitoring and Diagnostic Devices Market Outlook (2022-2027)
The global cardiovascular disease monitoring and diagnostic devices market is projected to rise at a CAGR of 6% from 2022 to 2027. The market is expected to secure a market value of around US$ 4.2 billion by 2027, up from US$ 3.14 billion in 2022.
Increasing prevalence of chronic cardiovascular diseases across the world is the major driver of the global cardiovascular disease monitoring devices market. The main cause of death worldwide, according to the World Health Organization, is cardiovascular disease. High salt intake, increasing tobacco use, increase in cigarette consumption, and excessive alcohol use are the main culprits contributing to the rising cases of cardiovascular illnesses.
Report Attributes |
Details |
|---|---|
|
Cardiovascular Disease Monitoring and Diagnostic Devices Market Size (2022) |
US$ 3.14 Billion |
|
Projected Market Value (2027) |
US$ 4.2 Billion |
|
Global Market Growth Rate (2022-2027) |
6% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Sales Analysis of Cardiovascular Disease Monitoring and Diagnostic Devices (2017-2021) Vs. Market Outlook (2022-2027)
According to Fact.MR, a market research and competitive intelligence provider, worldwide sales of cardiovascular disease monitoring and diagnostic devices are expected to increase at a CAGR of 6% from 2022 to 2027.
Depression, an inactive lifestyle, and bad eating practices all contribute to an increase in the prevalence of cardiovascular diseases. Monitoring and early diagnosis of the disease are essential for preventing future problems, and this understanding between the doctor and the patient facilitates the adoption of contemporary monitoring and diagnostic devices.
These devices include heart rate monitors, electrocardiograph systems, and others. The demand for cardiovascular devices is anticipated to be driven by an increase in the number of persons with diabetes and obesity.
Revenue growth in the cardiovascular disease monitoring and diagnostic devices market is anticipated to increase as a result of factors including the rising prevalence of heart diseases due to changes in lifestyle, growing patient knowledge and awareness of regular heart monitoring for extending life, and the compactness and ease of use of patient monitoring devices.
Which Markets Trends are Outlining the Demand for Cardiovascular Disease Monitoring & Diagnostic Systems?
“Continuous Technological Advancements in Cardiovascular Monitoring and Diagnosis Tools”
The rising focus on offering high-quality care to people by government organizations, ongoing technological advancements, and enhanced healthcare infrastructure are all anticipated to have a positive impact on the heart disease monitoring devices market over the coming years.
Advanced physiological bio-signals have been introduced as a result of growing recent innovations in cardiovascular monitoring and diagnosis tools. Automating diagnosis can increase the frequency with which anomalies in cardiovascular parameters are recognized at a high level. In addition, businesses are focusing their research efforts on the creation of enhanced cardiac monitors and heart rate monitors to increase the precision of patients' irregular heart rhythm monitoring.
Over the last few years, technologies employed in the creation of cardiovascular monitoring and diagnostic devices have advanced significantly, and the indications for these devices have increased. One such development is artificial intelligence, which has significantly enhanced the field of cardiology's ability to diagnose specific heart diseases.
There is a considerable rise in the prevalence of heart disorders worldwide, which fuels the demand for effective cardiovascular monitoring and diagnostic tools. The acceptance of modern technology is a result of its accessibility. The market has also been bolstered by efforts that have been adopted in response to the increase in demand for heart attack diagnostics devices in emerging economies.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What’s Preventing the Market from Reaching its Full Growth Potential?
“Lack of Skilled Professionals & High Price of Diagnostic Devices”
Surgeons with specialized training are needed to use cardiovascular monitoring and diagnostic devices to produce reliable, artefact-free recordings with high-quality clinical and diagnostic value. Furthermore, algorithms for implantable cardiac monitors are purposefully tuned for maximum sensitivity at the price of accuracy.
As a result, there are frequent false alarms that need to be investigated by medical specialists to prevent over-treating individuals. Therefore, using computed tomography treatments and heart rate monitors requires trained medical staff.
Market expansion is expected to be hampered by the undersupply of such equipment and skilled labor in developing and underdeveloped nations.
These devices' significantly high price tags are preventing a significant percentage of the consumer population from purchasing them. Additionally, one obstacle to the success of this sector is the absence of proper reimbursement rules in many developing countries.
The global market for cardiovascular monitoring and diagnostic devices is anticipated to see growth challenges due to the lengthy medical device approval process.
Which Region is Projected to Offer High Opportunity for Market Players?
“Rapidly Rising Adoption of Advanced Heart Rate Monitor Devices in North America”
Currently, the market for cardiovascular monitoring and diagnostic devices is dominated by North America.
- The American Heart Association, the Centers for Disease Control and Prevention, and the National Institutes of Health all agree that cardiovascular disease is currently the top cause of death worldwide and is expected to surpass around 23.6 million deaths by 2030.
The market is primarily driven by the rising adoption of advanced heart rate monitor devices, better reimbursement policies, effective healthcare infrastructure, and rising patient & physician awareness.
Rising need for cardiovascular monitoring and diagnostic devices, the presence of top cardiovascular monitoring and diagnostic device manufacturers, and easier access to healthcare facilities are driving the market growth in the region.
Country-wise Insights
How is the Cardiovascular Disease Monitoring and Diagnostic Devices Market Growth Unfolding in the U.S?
“Growing Usage of Efficient Cardiovascular Disease Monitoring and Diagnostic Devices in the U.S.”
The U.S. market is expanding due to factors such as a rising older population, a high prevalence of cardiovascular diseases, technological advancements in the creation of new products, and significant spending on R&D.
The market for cardiovascular devices is anticipated to benefit from supportive activities to raise disease awareness and the growing usage of efficient cardiovascular disease monitoring and diagnostic devices.
What is the Growth Outlook for Cardiovascular Disease Monitoring and Diagnostic Devices in China?
“Rising Government Investments in Advanced Healthcare Infrastructure in China”
The cardiovascular disease monitoring and diagnostic devices market in China is expected to increase at a CAGR of 10% from 2022 to 2027.
The market for cardiovascular disease monitoring and diagnostic equipment is anticipated to rise in China due to improving health care service standards, high demand for advanced imaging devices, and greater awareness of available therapies.
The large population, rising computed tomography demand, rising healthcare spending, and growing government investments in the creation of advanced healthcare infrastructure are likely to fuel the expansion of the market.
Category-wise Insights
Which Product is Likely to Contribute the Highest Market Growth?
“ECG Systems Gaining Traction Due to their Accuracy in Determining Electrical and Muscular Heart Functions”
Based on products, the cardiovascular disease monitoring and diagnostic devices market is classified into ECG systems, Holter monitors, implantable loop recorders, and others.
ECG systems account for 40% share of the global market owing to their accuracy in identifying the electrical and muscular functioning of the heart, the blood circulation to the heart tissue, and faster diagnosis of heart attacks.
Due to their low cost and excellent effectiveness in treating cardiac conditions, ECG systems are most frequently employed to diagnose cardiovascular illness worldwide. Due to their affordability, safety of the operation, and painlessness, the demand for ECG systems is projected to rise over the coming years.
A new generation of lightweight and compact ECGs is pushing their increased acceptance on the diagnostic and monitoring front, particularly in the remote cardiac monitoring market.
Prevalence of cardiovascular diseases (CVD), for which long-term ECG monitoring is required, has increased. Additionally, the availability of wireless ECG has allowed medical professionals to promptly monitor and diagnose patients from a distance.
Wearable cardiac monitors such as bands, watches, and rings, are among the new cardiac device technologies that have become commonplace for many people worldwide.
Which End User is Most Rewarding for Market Participants?
“Easy Accessibility of Advanced Products in Hospitals”
Based on end users, the market is segmented into hospitals, ambulatory surgical centers, and clinics. Demand for cardiovascular disease monitoring and diagnostic devices in hospitals is expected to rise at the highest CAGR over the coming years.
Factors such as the rising number of patients with various types of heart diseases being admitted into hospitals, favorable reimbursement policies, and the accessibility of innovative products in hospitals are likely to drive the segment growth over the coming years.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Companies in the cardiovascular disease monitoring market compete against both established local firms and international players. While others are buying and collaborating with other businesses that are now popular on the market, manufacturers of diagnostic devices are creating and launching novel products and innovations to compete with the existing offerings.
For instance :
- In 2021, MedStar Health released a tool that seamlessly determines a patient's risk of suffering a heart attack or stroke and presents it in their electronic health record with vibrant, user-friendly, and visualizations.
Segmentation of Cardiovascular Disease Monitoring and Diagnostic Devices Industry Research
-
By Product :
- ECG Systems
- Holter Monitors
- Implantable Loop Recorders
- Others
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Clinics
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product Type launches 5.2.2. Cost of Product Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product 6.4.2. Revenue By End User 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2021 7.2. Current and Future Market Volume (Units) Projections, 2022-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis 2017–2021 and Forecast, 2022-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2027 10.3.1. ECG Systems 10.3.2. Holter Monitors 10.3.3. Implantable Loop Recorders 10.3.4. Others 10.4. Market Attractiveness Analysis By Product 11. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2027 11.3.1. Hospitals 11.3.2. Ambulatory Surgical Centers 11.3.3. Clinics 11.4. Market Attractiveness Analysis By End User 12. Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 2017–2021 and Forecast 2022-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.2.1. By Product 20.2.2. By End User 20.3. Canada Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.3.1. By Product 20.3.2. By End User 20.4. Mexico Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.4.1. By Product 20.4.2. By End User 20.5. Brazil Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.5.1. By Product 20.5.2. By End User 20.6. U.K. Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.6.1. By Product 20.6.2. By End User 20.7. Germany Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.7.1. By Product 20.7.2. By End User 20.8. France Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.8.1. By Product 20.8.2. By End User 20.9. Italy Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.9.1. By Product 20.9.2. By End User 20.10. Spain Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.10.1. By Product 20.10.2. By End User 20.11. BENELUX Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.11.1. By Product 20.11.2. By End User 20.12. Russia Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.12.1. By Product 20.12.2. By End User 20.13. China Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.13.1. By Product 20.13.2. By End User 20.14. Japan Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.14.1. By Product 20.14.2. By End User 20.15. South Korea Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.15.1. By Product 20.15.2. By End User 20.16. India Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.16.1. By Product 20.16.2. By End User 20.17. ASEAN Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.17.1. By Product 20.17.2. By End User 20.18. Australia Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.18.1. By Product 20.18.2. By End User 20.19. New Zealand Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.19.1. By Product 20.19.2. By End User 20.20. GCC Countries Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.20.1. By Product 20.20.2. By End User 20.21. Turkey Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.21.1. By Product 20.21.2. By End User 20.22. South Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Analysis 20.22.1. By Product 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Medtronic 22.3.1.1. Overview 22.3.1.2. Product Type Portfolio 22.3.1.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Abbott 22.3.2.1. Overview 22.3.2.2. Product Type Portfolio 22.3.2.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. GE Healthcare 22.3.3.1. Overview 22.3.3.2. Product Type Portfolio 22.3.3.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. BIOTRONIK 22.3.4.1. Overview 22.3.4.2. Product Type Portfolio 22.3.4.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Boston Scientific Corporation 22.3.5.1. Overview 22.3.5.2. Product Type Portfolio 22.3.5.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Koninklijke Philips 22.3.6.1. Overview 22.3.6.2. Product Type Portfolio 22.3.6.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. BioTelemetry Inc. 22.3.7.1. Overview 22.3.7.2. Product Type Portfolio 22.3.7.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Mortara Instrument Inc. 22.3.8.1. Overview 22.3.8.2. Product Type Portfolio 22.3.8.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. Philips Healthcare 22.3.9.1. Overview 22.3.9.2. Product Type Portfolio 22.3.9.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Schiller AG 22.3.10.1. Overview 22.3.10.2. Product Type Portfolio 22.3.10.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Spacelabs Healthcare Inc. 22.3.11.1. Overview 22.3.11.2. Product Type Portfolio 22.3.11.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Welch Allyn 22.3.12.1. Overview 22.3.12.2. Product Type Portfolio 22.3.12.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Product
Table 02: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 03: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 04: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 06: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 07: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 08: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 09: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 10: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 11: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 12: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 13: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 14: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 15: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 16: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 17: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 18: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 19: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 20: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 21: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 22: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 23: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 24: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 25: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Volume (in 000' Units) Analysis, 2017-2021
Figure 02: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Volume Forecast (in 000' Units), 2022-2027
Figure 03: Cardiovascular Disease Monitoring and Diagnostic Devices Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Cardiovascular Disease Monitoring and Diagnostic Devices Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 06: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 07: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Absolute $ Opportunity, 2022-2027
Figure 08: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Share Analysis (%), By Product, 2022-2027
Figure 09: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Y-o-Y Analysis (%), By Product, 2022-2027
Figure 10: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 11: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Share Analysis (%), By End User, 2022-2027
Figure 12: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Y-o-Y Analysis (%), By End User, 2022-2027
Figure 13: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 14: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Share Analysis (%), By Region, 2022-2027
Figure 15: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Y-o-Y Analysis (%), By Region, 2022-2027
Figure 16: Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 18: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 19: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 20: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 21: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 22: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 23: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 24: North America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 25: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 26: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 29: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 30: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 31: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 32: Latin America Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 33: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 34: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 35: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 36: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 37: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 38: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 39: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 40: Europe Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 41: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 42: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 45: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 46: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 47: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 48: South Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 49: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 50: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 53: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 54: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 55: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 56: East Asia Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 57: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 58: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 61: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 62: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 63: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 64: Oceania Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 65: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 66: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2017-2021
Figure 69: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Forecast (US$ Mn), 2022-2027
Figure 70: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Product, 2022-2027
Figure 71: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by End User, 2022-2027
Figure 72: Middle East and Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Attractiveness Analysis by Country, 2022-2027
Figure 73: U. S. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 75: U. S. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 76: Canada Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 78: Canada Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 81: Mexico Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 84: Brazil Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 87: U. K. Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 88: Germany Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 90: Germany Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 91: France Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 93: France Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 94: Italy Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 96: Italy Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 97: Spain Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 99: Spain Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 100: Russia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 102: Russia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 103: China Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 105: China Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 106: Japan Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 108: Japan Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 111: South Korea Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 112: India Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 114: India Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 117: ASEAN Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 118: Australia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 120: Australia Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 123: New Zealand Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 126: GCC Countries Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 129: Turkey Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By Product, 2022 (E)
Figure 132: South Africa Cardiovascular Disease Monitoring and Diagnostic Devices Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the cardiovascular disease monitoring and diagnostic devices market?
The global cardiovascular disease monitoring and diagnostic devices market is valued at US$ 3.14 billion.
What is the projected growth rate for the market?
Product sales are expected to rise at 6% CAGR from 2022 to 2027.
What valuation will the market reach by 2027?
The market is set to reach a valuation of US$ 4.2 billion by 2027.
Who are the top cardiovascular disease monitoring and diagnostic device suppliers?
Medtronic, Abbott, and GE Healthcare are key cardiovascular disease monitoring and diagnostic device manufacturers.
Which are the top 5 countries in the market?
The U.S., Japan, Canada, China, and Germany lead the cardiovascular disease monitoring and diagnostic systems market.
What is the estimated CAGR for the market in Canada?
The market in Canada is set to rise at 5.5% CAGR through 2027.
Which product segment leads the market?
ECG systems account for 40% share of the global market.
Cardiovascular Disease Monitoring and Diagnostic Devices Market